1. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. (March 2019) Authors: Cabioglu, N.; Onder, S.; Oner, G.; Karatay, H.; Özkurt, E.; CanTrablus, D.; Tukenmez, M.; Muslumanoglu, M.; Saip, P.; Yavuz, E. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictive Factors to Achieve Pathologic Complete Response in Patients with Locally Advanced Breast Cancer in Decision Making for more Conservative Management. (April 2018) Authors: Can Trabulus, D.; Ozkurt, E.; Tukenmez, M.; Onder, S.; Muslumanoglu, M.; Igci, A.; Ozmen, V.; Dinccag, A.; Aydiner, A.; Cabioglu, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome. Issue 9 (September 2015) Authors: Karanlik, H.; Ozgur, I.; Cabioglu, N.; Sen, F.; Erturk, K.; Kilic, B.; Onder, S.; Deniz, M.; Yavuz, E.; Aydiner, A. Journal: European journal of surgical oncology Issue: Volume 41:Issue 9(2015:Sep.) Page Start: 1226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗